Education
About Us
Working with TipRanks
Follow Us
AEON Biopharma (AEON)
:AEON
Total Valuation
AEON Biopharma has a market cap or net worth of $5.76M. The enterprise value is ―.
Market Cap$5.76M
Enterprise Value―
Share Statistics
AEON Biopharma has 11,305,367 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding11,305,367
Owned by Insiders16.01%
Owned by Institutions14.25%
Financial Efficiency
AEON Biopharma’s return on equity (ROE) is 0.18 and return on invested capital (ROIC) is 7174.01%.
Return on Equity (ROE)0.18
Return on Assets (ROA)-4.88
Return on Invested Capital (ROIC)7174.01%
Return on Capital Employed (ROCE)0.67
Revenue Per Employee0.00
Profits Per Employee-10.51M
Employee Count5
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of AEON Biopharma is 0.00. AEON Biopharma’s PEG ratio is <0.01.
PE Ratio0.00
PS Ratio0.00
PB Ratio-1.09
Price to Fair Value0.00
Price to FCF-0.05
Price to Operating Cash Flow-1.78
PEG Ratio<0.01
Income Statement
In the last 12 months, AEON Biopharma had revenue of 0.00 and earned -52.56M in profits. Earnings per share was 0.00.
Revenue0.00
Gross Profit0.00
Operating Income-48.43M
Pretax Income-52.56M
Net Income-52.56M
EBITDA-48.36M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -19.67M and capital expenditures 0.00, giving a free cash flow of -19.67M billion.
Operating Cash Flow-19.67M
Free Cash Flow-19.67M
Free Cash Flow per Share-1.74
Dividends & Yields
AEON Biopharma pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.80
52-Week Price Change-99.66%
50-Day Moving Average0.52
200-Day Moving Average33.46
Relative Strength Index (RSI)35.79
Average Volume (3m)338.58K
Important Dates
AEON Biopharma upcoming earnings date is Aug 18, 2025, TBA Not Confirmed.
Last Earnings DateMay 14, 2025
Next Earnings DateAug 18, 2025
Ex-Dividend Date―
Financial Position
AEON Biopharma as a current ratio of 0.12, with Debt / Equity ratio of -51.42%
Current Ratio0.12
Quick Ratio0.12
Debt to Market Cap0.00
Net Debt to EBITDA-2.52
Interest Coverage Ratio0.00
Taxes
In the past 12 months, AEON Biopharma has paid -160.49K in taxes.
Income Tax-160.49K
Effective Tax Rate<0.01
Enterprise Valuation
AEON Biopharma EV to EBITDA ratio is -2.52, with an EV/FCF ratio of -3.39.
EV to Sales0.00
EV to EBITDA-2.52
EV to Free Cash Flow-3.39
EV to Operating Cash Flow-3.42
Balance Sheet
AEON Biopharma has $537.00K in cash and marketable securities with $16.50M in debt, giving a net cash position of $15.96M billion.
Cash & Marketable Securities$537.00K
Total Debt$16.50M
Net Cash$15.96M
Net Cash Per Share$1.41
Tangible Book Value Per Share$0.00
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for AEON Biopharma is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast-261.69%